PET imaging validates use of common cholesterol drug to enhance HER2-targeted cancer therapy
Consultant PET photographs of 89ZrDFO-trastuzumab displaying %ID/g acquired 48 hours after radiolabeled trastuzumab injection on day 39 for T-DM1 single-treatment regime, ...